Joint Venture (SK Plasma/PT Infion) Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Joint Venture (SK Plasma/PT Infion) General Information

Description

Producer of pharmaceuticals intended to treat blood diseases. The company offers medicines used to treat diseases caused by the lack of a specific component in the blood enabling its customers to get their required services.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Indonesia
Primary Industry
Biotechnology
Corporate Office
  • Indonesia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Joint Venture (SK Plasma/PT Infion) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Joint Venture (SK Plasma/PT Infion)‘s full profile, request access.

Request a free trial

Joint Venture (SK Plasma/PT Infion) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Joint Venture (SK Plasma/PT Infion)‘s full profile, request access.

Request a free trial

Joint Venture (SK Plasma/PT Infion) FAQs

  • When was Joint Venture (SK Plasma/PT Infion) founded?

    Joint Venture (SK Plasma/PT Infion) was founded in 2023.

  • Where is Joint Venture (SK Plasma/PT Infion) headquartered?

    Joint Venture (SK Plasma/PT Infion) is headquartered in Indonesia.

  • What industry is Joint Venture (SK Plasma/PT Infion) in?

    Joint Venture (SK Plasma/PT Infion)’s primary industry is Biotechnology.

  • Is Joint Venture (SK Plasma/PT Infion) a private or public company?

    Joint Venture (SK Plasma/PT Infion) is a Private company.

  • What is Joint Venture (SK Plasma/PT Infion)’s current revenue?

    The current revenue for Joint Venture (SK Plasma/PT Infion) is .

  • Who are Joint Venture (SK Plasma/PT Infion)’s investors?

    Infion and SK Plasma have invested in Joint Venture (SK Plasma/PT Infion).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process